CE Marking Consulting & Technical Support

A CE mark indicates that a product conforms to applicable European Union requirements for safety, health, and performance. For medical devices, it shows the manufacturer has met relevant EU MDR obligations, completed the appropriate conformity assessment route, and prepared supporting technical documentation, labeling, risk management, and clinical evidence needed to place the device on the EU market.

CE marking is ultimately affixed by the manufacturer after demonstrating conformity with applicable EU requirements. For many medical devices, especially higher-risk classes, an accredited Notified Body must review the technical documentation and quality system before certification can support CE marking. Consultants like Elexes do not issue the mark; they help manufacturers prepare compliant documentation, strategy, and evidence.

CE marking costs vary based on device classification, technical complexity, testing needs, clinical evidence gaps, and whether a Notified Body review is required. Costs typically include consulting support, documentation remediation, testing, translations, quality system work, and Notified Body fees. A structured readiness assessment often reduces total cost by identifying deficiencies early and preventing expensive submission delays or rework.

Most medical devices need a technical documentation package aligned with EU MDR Annex II and III. This commonly includes device description, intended use, classification rationale, GSPR checklist, risk management file, verification and validation data, clinical evaluation, labeling and IFU, post-market surveillance documentation, and Declaration of Conformity. The exact set depends on device class, technology, and conformity assessment route.

Timelines depend on device class, documentation maturity, testing status, and Notified Body availability. A well-prepared lower-risk device may move faster, while higher-risk devices with clinical evidence gaps or incomplete technical files can take substantially longer. Many delays come from remediation work, weak traceability, or avoidable review questions, which is why readiness and gap assessments are valuable early steps.

No. Some lower-risk devices may follow self-declaration routes, but many medical devices require Notified Body involvement under EU MDR. The need depends on classification, device characteristics, and applicable conformity assessment procedures. Higher-risk devices, implantables, sterile products, and devices with measuring functions often require external review of the quality system, technical documentation, or both.

Yes. Elexes supports technical file remediation by identifying missing or weak sections, mapping gaps to specific EU MDR requirements, and helping teams rebuild documentation in a structured way. This can include GSPR matrices, risk management alignment, CER support, labeling updates, post-market documentation, and cross-referencing evidence so the file is clearer and more defensible for Notified Body review.

Deficiencies usually trigger questions, nonconformities, or requests for clarification and additional evidence. The key is responding with precise, well-supported remediation rather than isolated document edits. A strong response addresses root gaps in technical documentation, risk files, clinical evidence, labeling, or QMS alignment. Expert support can help prioritize actions, coordinate updates, and improve the quality of the resubmission package.